| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | AdvanCell Isotopes is involved in the production and supply of Alpha Emitting Isotopes for Targeted Alpha Therapy for cancer. Targeted Alpha Therapy is a revolutionary treatment that uses alpha-emitting isotopes attached to molecules that deliver cytotoxic radiation direct to tumours, i.e. radiotherapy at the molecular level. AdvanCell’s goal is a safe and effective treatment for patients with multiple forms of cancer, that will become a standard of care. |
| Category: | Health & biotech |
| URL: | http://www.advancell.com.au |
| Operational Status: | Active |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | 2019 |
| Address: | Level 7, 167 Macquarie Street, Sydney, New South Wales 2000, AU |
| State: | New South Wales |
| Overseas Operations: | No |
| Twitter: | |
| Facebook: | |
| Linkedin: | https://www.linkedin.com/company/advancell |
| Founders: | |
| Awards won: | |
